Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (281-290 of 504) with videos related to

Pageof 51
Sort By:
Blood Advances|February 7, 2019
Genome-wide promoter methylation of hairy cell leukemiaAlberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaPietro Bulian, Tait D Shanafelt, Chris Fegan, et al.
Human Pathology|October 16, 2002
Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entityMarco Paulli, Alessandra Viglio, Daniela Vivenza, et al.
Frontiers in Neurology|January 7, 2021
Preservation of Language Processing and Auditory Performance in Patients With Disorders of Consciousness: A Multimodal AssessmentStefania Ferraro, Anna Nigri, Ludovico D'Incerti, et al.
Frontiers in Neurology|March 5, 2021
Corrigendum: Preservation of Language Processing and Auditory Performance in Patients With Disorders of Consciousness: A Multimodal AssessmentStefania Ferraro, Anna Nigri, Ludovico D'Incerti, et al.
Reviews in Cardiovascular Medicine|September 4, 2024
Current Antithrombotic Treatments for Cardiovascular Diseases: A Comprehensive ReviewKristian Galanti, Mario Di Marino, Davide Mansour, et al.
Hematological Oncology|July 30, 2010
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemiaPietro Bulian, Michela Tarnani, Davide Rossi, et al.
Blood|March 5, 2009
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomasUrban Novak, Andrea Rinaldi, Ivo Kwee, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Haematologica|June 29, 2014
Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patientsMarco Montillo, Alessandra Tedeschi, Gianluca Gaidano, et al.
Pageof 51

Showing results (281-290 of 504) with videos related to

Sort By:
Pageof 51
Blood Advances|February 7, 2019
Genome-wide promoter methylation of hairy cell leukemiaAlberto J Arribas, Andrea Rinaldi, Giorgia Chiodin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaPietro Bulian, Tait D Shanafelt, Chris Fegan, et al.
Human Pathology|October 16, 2002
Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entityMarco Paulli, Alessandra Viglio, Daniela Vivenza, et al.
Frontiers in Neurology|January 7, 2021
Preservation of Language Processing and Auditory Performance in Patients With Disorders of Consciousness: A Multimodal AssessmentStefania Ferraro, Anna Nigri, Ludovico D'Incerti, et al.
Frontiers in Neurology|March 5, 2021
Corrigendum: Preservation of Language Processing and Auditory Performance in Patients With Disorders of Consciousness: A Multimodal AssessmentStefania Ferraro, Anna Nigri, Ludovico D'Incerti, et al.
Reviews in Cardiovascular Medicine|September 4, 2024
Current Antithrombotic Treatments for Cardiovascular Diseases: A Comprehensive ReviewKristian Galanti, Mario Di Marino, Davide Mansour, et al.
Hematological Oncology|July 30, 2010
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemiaPietro Bulian, Michela Tarnani, Davide Rossi, et al.
Blood|March 5, 2009
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomasUrban Novak, Andrea Rinaldi, Ivo Kwee, et al.
Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.
Haematologica|June 29, 2014
Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patientsMarco Montillo, Alessandra Tedeschi, Gianluca Gaidano, et al.
Pageof 51